Drug Type Small molecule drug |
Synonyms 1ST 104, 1ST-104 |
Target |
Action modulators |
Mechanism ABL1 modulators(ABL proto-oncogene 1 modulators), LRRK2 modulators(Leucine-rich repeat serine/threonine-protein kinase 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Parkinson Disease | Discovery | South Korea | 01 May 2025 | |
| Amyotrophic Lateral Sclerosis | Discovery | South Korea | - | |
| Olivopontocerebellar Atrophies | Discovery | South Korea | - |





